Clinical Trial Update: Safety and Efficacy of I-020502 in Meshed Skin Autografting [Phase 2]

View source ↗

Summary

Phase 2 trial assessing safety and efficacy of I-020502 in meshed skin autografting for burns has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Burns

Drugs mentioned

• I-020502

Snippet

Sponsor: Kuros Biosurgery AG | Conditions: Burns | Phase 2 | Status: COMPLETED